Cargando…

The effect of telemedicine on secondary prevention of atherosclerotic cardiovascular disease: A systematic review and meta-analysis

AIM: The purpose of this systematic review was to evaluate the efficiency of telemedicine on the secondary level of prevention of patients with arteriosclerotic cardiovascular disease (ASCVD), provide evidence for the application of telemedicine in secondary prevention and promote the development of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Liangying, Wu, Qing, Ding, Feng, Liu, Yanfeng, Shen, Jianping, Lin, Yan, Shi, Kaihu, Zeng, Bailin, Wu, Lixing, Tong, Huangjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683074/ https://www.ncbi.nlm.nih.gov/pubmed/36440018 http://dx.doi.org/10.3389/fcvm.2022.1020744

Ejemplares similares

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
por: Wu, Min, et al.
Publicado: (2021)

Remnant cholesterol and atherosclerotic cardiovascular disease: Metabolism, mechanism, evidence, and treatment
por: Wang, Kexin, et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Disease Risk and Lipid-Lowering Therapy Requirement in China
por: Bi, Lei, et al.
Publicado: (2022)

The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease
por: Smeets, Diede, et al.
Publicado: (2022)

Telemedicine: Benefits for Cardiovascular Patients in the COVID-19 Era
por: Ghilencea, Liviu-Nicolae, et al.
Publicado: (2022)

Association Between Periodontal Disease and Atherosclerotic Cardiovascular Diseases: Revisited
por: Zardawi, Faraedon, et al.
Publicado: (2021)

Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue
por: Gabbiadini, Roberto, et al.
Publicado: (2023)

Repostioning of Telemedicine in Cardiovascular World Post-COVID-19 Pandemic
por: Sharma, Kamal, et al.
Publicado: (2022)

E3 Ubiquitin Ligases as Immunotherapeutic Target in Atherosclerotic Cardiovascular Disease
por: Poels, Kikkie, et al.
Publicado: (2020)

The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease
por: Finney, Alexandra C., et al.
Publicado: (2023)

Common variable immunodeficiency—an independent risk factor for atherosclerotic cardiovascular diseases
por: Mattila, Juho, et al.
Publicado: (2023)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Predictive value of 10-year atherosclerotic cardiovascular disease risk equations from the China-PAR for new-onset lower extremity peripheral artery disease
por: He, Pengkang, et al.
Publicado: (2022)

Achievement of low-density lipoprotein cholesterol targets in Chinese patients with atherosclerotic cardiovascular disease after receiving statins and ezetimibe
por: Cheng, Yinchu, et al.
Publicado: (2022)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor
por: Nahmias, Avital, et al.
Publicado: (2020)

Effect of PCSK9 on atherosclerotic cardiovascular diseases and its mechanisms: Focus on immune regulation
por: Ma, Minglu, et al.
Publicado: (2023)

Effect of causative genetic variants on atherosclerotic cardiovascular disease in heterozygous familial hypercholesterolemia patients
por: Matta, Anthony, et al.
Publicado: (2023)

Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study
por: Yang, Quanhe, et al.
Publicado: (2017)

Effects of norepinephrine on plaque hypoxia in atherosclerotic rabbits
por: Wang, Jia-Yu, et al.
Publicado: (2023)

Proteotoxic stress response in atherosclerotic cardiovascular disease: Emerging role of heat shock factor 1
por: Ghai, Shruti, et al.
Publicado: (2023)

DNA methylation changes underlie the long-term association between periodontitis and atherosclerotic cardiovascular disease
por: Omar, Mohamed, et al.
Publicado: (2023)

Cumulative non-high-density lipoprotein cholesterol burden and risk of atherosclerotic cardiovascular disease: a prospective community-based study
por: Guan, Xu-Min, et al.
Publicado: (2023)

NLRP3 Inflammasome Signaling as a Link Between HIV-1 Infection and Atherosclerotic Cardiovascular Disease
por: Mullis, Caroline, et al.
Publicado: (2020)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Prevalence, awareness, treatment, and risk factor control of high atherosclerotic cardiovascular disease risk in Guangzhou, China
por: Liu, Hui, et al.
Publicado: (2023)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
por: Gourdy, Pierre, et al.
Publicado: (2023)

Global eligibility and cost effectiveness of icosapent ethyl in primary and secondary cardiovascular prevention
por: Toth, Peter P., et al.
Publicado: (2023)

The relationship between atherosclerotic disease and relapse during ATD treatment
por: Zhu, Xinxin, et al.
Publicado: (2022)

The relationship between Type D personality with atherosclerotic plaque and cardiovascular events: The mediation effect of inflammation and kynurenine/tryptophan metabolism
por: Wang, Yini, et al.
Publicado: (2022)

Inflammatory Mediators in Atherosclerotic Vascular Remodeling
por: Evans, Bryce R., et al.
Publicado: (2022)

Interaction analysis of the new pooled cohort equations for 10-year atherosclerotic cardiovascular disease risk estimation: a simulation analysis
por: Schiros, Chun G, et al.
Publicado: (2015)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
por: Barrios, Vivencio, et al.
Publicado: (2022)

Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study
por: Henderson, Kamal, et al.
Publicado: (2022)

Defective Protein Catabolism in Atherosclerotic Vascular Inflammation
por: Miyazaki, Takuro, et al.
Publicado: (2017)

Artificial intelligence in atherosclerotic disease: Applications and trends
por: Kampaktsis, Polydoros N., et al.
Publicado: (2023)

Are acute type A aortic dissections atherosclerotic?
por: Grewal, Nimrat, et al.
Publicado: (2023)

Secondary prevention of antithrombotic therapy in patients with stable cardiovascular disease at high ischemic risk: A network meta-analysis of randomized controlled trials
por: Zhu, Houyong, et al.
Publicado: (2023)

Secondary Prevention Using Cholesterol-Lowering Medications in Patients with Prior Atherosclerotic Cardiovascular Disease Events: A Retrospective Cohort Analysis
por: Han, Xue, et al.
Publicado: (2022)

Efficacy and safety of hybutimibe in combination with atorvastatin for treatment of hypercholesteremia among patients with atherosclerotic cardiovascular disease risk equivalent: A multicenter, randomized, double-blinded phase III study
por: Qi, Litong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7dbhak4la0bj154is88auoc9dd